TABLE 1

Clinical characteristics of patients with NGT, IGT, and/or IFG and patients with diabetes

ParameterNGTIGT/IFGDiabetesP
Age (years)55.9 ± 15.963.2 ± 13.959.0 ± 10.10.30
Sex (female/male)5/38/63/80.22
Clinical diagnoses
    Chronic pancreatitis3 (38)7 (50)7 (64)0.52
    Benign adenoma5 (63)6 (43)3 (27)0.31
    Ampullary tumor0 (0)1 (7)1 (9)0.70
BMI (kg/m2)23.6 ± 2.723.4 ± 3.224.1 ± 4.70.69
Waist-to-hip ratio0.89 ± 0.070.89 ± 0.080.90 ± 0.060.89
RR systolic (mmHg)116 ± 18119 ± 35125 ± 200.77
RR diastolic (mmHg)72 ± 973 ± 1378 ± 100.44
A1C (%)5.7 ± 0.55.7 ± 0.56.9 ± 1.4*0.0086
White blood count (n/μl)8,024 ± 1,3386,717 ± 2,1006,236 ± 1,8450.13
Hemoglobin (g/dl)13.8 ± 1.113.2 ± 1.513.8 ± 1.50.45
Serum amylase (units/l)41.6 ± 41.671.5 ± 74.313.8 ± 1.50.45
Serum urea (mg/dl)31.9 ± 4.231.2 ± 4.131.5 ± 2.90.99
Serum creatinine (mg/dl)0.97 ± 0.110.99 ± 0.081.0 ± 0.060.98
Triglycerides (mg/dl)100.3 ± 34.9121.9 ± 49.8155.2 ± 72.10.13
Cholesterol (mg/dl)209.9 ± 37.0207.2 ± 45.5204.5 ± 56.00.97
HDL cholesterol (mg/dl)64.0 ± 22.652.4 ± 24.044.7 ± 14.50.20
LDL cholesterol (mg/dl)136.2 ± 36.8143.5 ± 28.0137.6 ± 39.30.87
  • Data are means ± SD, n, or n (%). Statistical analysis used ANOVA or χ2 test.

  • *Significantly different vs. control subjects (Duncan's post hoc test).